Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for separating relevant substances of hydrochloric acid palonosetron injection by virtue of reversion phase chromatography

A palonosetron and separation method technology, which is applied in the field of reversed-phase high-performance liquid chromatography for separation of related substances in palonosetron hydrochloride injection, can solve the problems of unsuitable practical operation, damage to instruments and chromatographic columns, and failure to achieve a single separation and other problems, to achieve high sensitivity, simple and convenient method, and good reproducibility

Active Publication Date: 2017-11-07
HANGZHOU XINBOSI BIOMEDICAL CO LTD
View PDF10 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Chinese patent CN104764840A discloses the separation method of impurity A, diastereoisomer, and enantiomer, but does not involve impurity B, E, and does not achieve the effect of one-time separation, and in this method, ion pair reagent is used as flow The phase is run with a gradient, and the general ion-pairing reagent has irreversible damage to the instrument and chromatographic column, which is not suitable for practical operation
[0005] Therefore the prior art does not solve the problem that the impurity of Palonosetron Hydrochloride Injection is difficult to detect and separate, so research and development of a kind of analytical method for quickly and effectively separating the above-mentioned specific impurities in Palonosetron Hydrochloride Injection will affect the quality of pharmaceutical products. control is very important

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for separating relevant substances of hydrochloric acid palonosetron injection by virtue of reversion phase chromatography
  • Method for separating relevant substances of hydrochloric acid palonosetron injection by virtue of reversion phase chromatography
  • Method for separating relevant substances of hydrochloric acid palonosetron injection by virtue of reversion phase chromatography

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] 1. Instruments and reagents:

[0026] Agilent 1260 liquid chromatograph equipped with G1314F ultraviolet detector and HPLC chromatographic workstation equipped with analytical instruments. Acetonitrile (chromatographic grade), methanol (chromatographic grade), diethylamine (analytical grade), glacial acetic acid (analytical grade), purified water.

[0027] 2. Chromatographic conditions:

[0028] Chromatographic column: CHIROBIOTIC T column (4.6×250mm, 5.0μm)

[0029] Detection wavelength: 238nm

[0030] Column temperature: 40°C

[0031] Flow rate: 1.0ml / min

[0032] Injection volume: 100μl

[0033] Mobile phase: mobile phase A: mobile phase B=40:60, where mobile phase A is methanol:acetonitrile=90:10, mobile phase B is 0.5% diethylamine aqueous solution (adjust pH to 5.0 with glacial acetic acid).

[0034] Diluent: mobile phase

[0035] 3. Solution Preparation

[0036] To prepare a system suitability solution:

[0037] (1) Impurity A solution: Weigh about 25mg ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
wavelengthaaaaaaaaaa
Login to View More

Abstract

The invention relates to a high performance liquid chromatography for reverse-phase separation of a hydrochloric acid palonosetron injection and specific impurities of the injection. According to the chromatography, a macrocyclic glycopeptides chiral column is adopted, in which a volume ratio of a flow phase (a ratio of methanol to acetonitrile is 90 to 10) to 0.5% diethylamine water solution is (40 to 60)-(50 to 50), a detection wavelength is 238nm, a column temperature is 35-40 DEG C, and a flow speed is 0.8ml / min-1.2ml / min. By virtue of the chromatography, the specific impurities A, B, E, enantiomers and diastereoisomers collected in America pharmacopeia USP39 can be completely separated; and furthermore, the chromatography is simple, accurate and high in sensitivity, and can be used for detecting relevant substances of the hydrochloric acid palonosetron injection.

Description

technical field [0001] The invention belongs to the field of analytical chemistry, and in particular relates to a method for separating related substances of palonosetron hydrochloride injection by reverse-phase high-performance liquid chromatography. Background technique [0002] Palonosetron Hydrochloride (Palonosetron Hydrochloride), trade name: Aloxi, chemical name 2-(1-azabicyclo[2,2,2]oct-3S-yl-2,3,3aS,4,5 ,6-Hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride is a highly efficient, selective and competitive 5-hydroxytryptamine 3 receptor antagonist developed by Helsinn, Switzerland. FDA-approved for the prevention of acute and delayed nausea and vomiting associated with initiation and repeat courses of moderately and highly emetogenic chemotherapy (CT), and the only option for delayed CINA (chemotherapy-induced nausea and vomiting) 5-hydroxytryptamine receptor blocker. The structural formula of palonosetron hydrochloride is as follows: [0003] [0004] Accordi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N30/02G01N30/06
CPCG01N30/02G01N30/06
Inventor 江佳佳周卫枫郑春燕何彩霞沈凤梅刘艳华
Owner HANGZHOU XINBOSI BIOMEDICAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products